1. Home
  2. GHRS vs SLDP Comparison

GHRS vs SLDP Comparison

Compare GHRS & SLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • SLDP
  • Stock Information
  • Founded
  • GHRS 2018
  • SLDP 2011
  • Country
  • GHRS Ireland
  • SLDP United States
  • Employees
  • GHRS N/A
  • SLDP N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • SLDP Electrical Products
  • Sector
  • GHRS Health Care
  • SLDP Energy
  • Exchange
  • GHRS Nasdaq
  • SLDP Nasdaq
  • Market Cap
  • GHRS 774.1M
  • SLDP 645.4M
  • IPO Year
  • GHRS 2021
  • SLDP N/A
  • Fundamental
  • Price
  • GHRS $13.53
  • SLDP $6.42
  • Analyst Decision
  • GHRS Strong Buy
  • SLDP Strong Buy
  • Analyst Count
  • GHRS 9
  • SLDP 1
  • Target Price
  • GHRS $29.33
  • SLDP $4.00
  • AVG Volume (30 Days)
  • GHRS 274.3K
  • SLDP 15.5M
  • Earning Date
  • GHRS 11-07-2025
  • SLDP 11-04-2025
  • Dividend Yield
  • GHRS N/A
  • SLDP N/A
  • EPS Growth
  • GHRS N/A
  • SLDP N/A
  • EPS
  • GHRS N/A
  • SLDP N/A
  • Revenue
  • GHRS N/A
  • SLDP $22,667,000.00
  • Revenue This Year
  • GHRS N/A
  • SLDP $27.38
  • Revenue Next Year
  • GHRS N/A
  • SLDP $37.97
  • P/E Ratio
  • GHRS N/A
  • SLDP N/A
  • Revenue Growth
  • GHRS N/A
  • SLDP 14.83
  • 52 Week Low
  • GHRS $6.72
  • SLDP $0.68
  • 52 Week High
  • GHRS $20.50
  • SLDP $8.05
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 50.01
  • SLDP 59.47
  • Support Level
  • GHRS $12.50
  • SLDP $5.19
  • Resistance Level
  • GHRS $14.44
  • SLDP $6.32
  • Average True Range (ATR)
  • GHRS 1.04
  • SLDP 0.66
  • MACD
  • GHRS 0.01
  • SLDP -0.07
  • Stochastic Oscillator
  • GHRS 45.24
  • SLDP 43.00

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About SLDP Solid Power Inc.

Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.

Share on Social Networks: